REVVITY, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data REVVITY, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,116	2,257	2,778	2,884	3,783	3,828	3,312	2,751	2,755	2,856
Cost of revenue	665	709	1,437
Gross profit	1,013	1,074	1,341	1,396	2,110	2,434	1,990
Research and development	124	139	194	189	146	200	222	217	197	216
Selling, general and administrative	590	626	812	815	716	975	1,026	1,023	994	992
Operating income	295	296	324	362	867	1,258	743	301	347	357
Interest expense	41.5	43.9	67	63.6	49.7		104	98.8	96.3	92.2
Interest income	0.7	2.57	1.14	1.5	1.01	2.24	3.59	72.1	73.2	31.1
Other non-operating income	-50.5	1.1	-66.2	-125	-67.2	-54.9	-90.9	-118	-30.6	-88.4
Pre-tax income	244	297	258	237	800	1,204	652	183	316	268
Income tax	28.4	140	20.2	9.39	170	314	139	3.47	33.1	28.4
Income from continuing operations	216	157	237	228	631	889	513	180	283	240
Net income	234	293	238	228	728	943	569	693	270	241
EBITDA	395	401	504	576	1,069	1,570	1,170	732	775	762
EPS, basic	2.14	2.67	2.15	2.06	6.52	8.12	4.51	5.56	2.21	2.07
EPS, diluted	2.12	2.64	2.13	2.04	6.49	8.08	4.50	5.55	2.20	2.07
Shares, basic (weighted)	109	110	111	111	112	116	126	125	123	117
Shares, diluted (weighted)	110	111	112	112	112	117	126	125	123	117
Dividend per share	0.28	0.28	0.28	0.28	0.28		0.28	0.28	0.28	0.28

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	359	202	163	192	387	603	454	913	1,163	920
Short-term investments							0	690	0
Receivables	426	552	633	725	1,155	708	613	633	632	745
Inventory	247	352	338	357	515	426	405	428	368	379
Other current assets	99.2	93.8	101	100	167	148	122	337	186	196
Total current assets	1,190	1,200	1,235	1,374	2,239	2,441	3,289	3,001	2,350	2,240
Property, plant and equipment	145	298	319	318	368	486	483	510	482	479
Lease right-of-use assets			0	167	207	164	188	155	168	165
Goodwill	2,248	3,002	2,953	3,111	2,640	6,627	6,482	6,534	6,464	6,613
Intangible assets	420	1,347	1,200	1,283	1,366	3,822	3,377	3,022	2,641	2,347
Long-term investments					2.15	33.7	11.1	13.9	27.4	28
Other non-current assets	205	244	270	284	333	317	311	343	288	323
Total assets	4,277	6,091	5,976	6,539	7,960	15,001	14,130	13,565	12,392	12,168
Accounts payable	168	222	221	236	327	325	273	204	167	185
Accrued liabilities	400	501	529	503	944	679	528	524	485	557
Deferred revenue	163	160	30.8	29.9	238	185	30.1	22.5	140	159
Short-term debt	1.17	217	14.9	9.97	381	4.24	471	722	0.24	589
Total current liabilities	603	951	772	763	1,652	1,214	1,544	1,450	653	1,331
Long-term debt	1,045	1,789	1,877	2,064	1,610	4,980	3,923	3,178	3,150	2,631
Lease liabilities			0	146	188	147	170	133	152	148
Other non-current liabilities	460	849	742	751	775	1,427	1,109	931	771	807
Total liabilities	2,123	3,588	3,391	3,725	4,225	7,859	6,747	5,692	4,726	4,918
Total debt	1,046	2,006	1,891	2,074	1,991	4,984	4,394	3,900	3,151	3,220
Paid-in capital	26.1	58.8	48.8	90.4	148	2,761	2,753	2,417	2,097	1,306
Retained earnings	2,119	2,381	2,602	2,812	3,507	4,417	4,951	5,609	5,845	6,054
Other comprehensive income	-101	-46.5	-176	-200	-32	-163	-447	-277	-396	-222
Shareholders' equity	2,154	2,503	2,585	2,814	3,735	7,141	7,383	7,873	7,667	7,250
Total equity	2,154	2,503	2,585	2,814	3,735	7,141	7,383	7,873	7,667	7,250
Total liabilities and equity	4,277	6,091	5,976	6,539	7,960	15,001	14,130	13,565	12,392	12,168
Shares outstanding	110	110	110	111	112	126	126	123	121	112

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	234	293	238	228	728	943	569	693	270	241
Depreciation and amortization	100	105	181	214	202	311	427	432	428	405
Stock-based compensation	17.2	25.4	28.8	31.5	26.9	29.7	51.5	41.4	37.8	22.8
Deferred income tax	-4.55	28.9	-51.1	-61.4	-35.3	-55.3	-106	-124	-102	-61.5
Change in receivables	-19	-36.6	-94.5	101	399	-166	66.1	-9	-16	-101
Change in inventory	6.75	-17.9	-30.2	9.61	127	-32.3	-48.6	-14.1	45.1	14.8
Change in payables	30.7	34.3	8.9	7.35	63.2	-7.58	-43.8	-76.4	-26	7.35
Cash from operations	351	288	311	363	892	1,411	680	91.3	628	583
Capital expenditures	-31.7	-39.1	-93.3	-76.3	-63.6	-86	-85.6	-81.4	-86.6	-73.5
Purchases of investments	0	-10.8	-7.02	-6.39	-20.1	-23.1	-47.2	-6.3	0	0
Sales and maturities of investments							0	550	710	0
Cash from investing	-83.9	-1,267	-160	-488	-504	-4,113	-133	1,314	776	-17.4
Debt issued	546	0	369	847	0	3,086	0	0
Debt repaid		0	0	-530	0	-340	-57.9	-524	-711	0
Share buybacks	-152	-3.83	-57.4	-6.31	-6.94	-73.1	-80.6	-389	-370	-821
Dividends paid	-30.8	-30.8	-31	-31.1	-31.2	-32.4	-35.3	-35	-34.5	-32.8
Cash from financing	-115	782	-179	-150	-203	2,942	-662	-947	-1,128	-858
Exchange rate effect	-13.4	21.7	-8	-0.45	25.9	-22.9	-33.7	-14	-26.1	48.5
Net change in cash	138	-174	-36.1	25.6	211	217	-149	444	250	-243
Free cash flow	319	249	218	287	829	1,325	594	9.9	542	509
Interest paid	30.7	35.8	56.5	82.7	42.1	54.1	97.9	94	91.1	86.2
Income taxes paid	43.5	77.6	59.8	77.1	162	365	323	360	155	131

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 5, 2026; growth uses fiscal years. Valuation uses the share price of $151.11 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	12.3%	Operating income / revenue.
EBITDA margin	20.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	9.0%	Pre-tax income / revenue.
Net margin	8.2%	Net income / revenue.
FCF margin	19.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.6%	Cash from operations / revenue.
Effective tax rate	9.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.0%	Net income / average total assets.
Return on invested capital (ROIC)	3.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	7.4%	Research and development expense / revenue.
SG&A / revenue	35.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.4%	Capital expenditures / revenue.
D&A / revenue	8.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-5.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	2.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-21.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-16.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-1.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-13.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-6.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-10.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-24.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-19.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-5.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-22.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-20.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-7.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-5.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-8.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-6.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-5.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-9.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.80x	Current assets / current liabilities.
Quick ratio	1.36x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.80x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.44x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	26.6%	Total debt / total assets.
Liabilities / assets	40.0%	Total liabilities / total assets.
Net debt	$2.18B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.62x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.82x	Operating income / interest expense.
Working capital	$1.02B	Current assets - current liabilities.
Goodwill and intangibles / assets	73.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.60B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.24x	Revenue / average total assets.
Fixed asset turnover	6.38x	Revenue / average property, plant and equipment.
Receivables turnover	4.11x	Revenue / average receivables.
Days sales outstanding	89 days	365 x average receivables / revenue.
FCF conversion	234.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.13	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.08	Revenue / diluted weighted shares.
FCF per share	$5.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.62	Cash from operations / diluted weighted shares.
Book value per share	$64.78	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$14.37	Tangible book value / shares outstanding.
Cash per share	$9.17	(Cash + short-term investments) / shares outstanding.
Payout ratio	13.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	5.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	85.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$16.86B	Share price x shares outstanding.
Enterprise value	$19.04B	Market cap + total debt - cash - short-term investments.
P/E	71.0x	Market cap / net income. Only when net income is positive.
P/S	5.79x	Market cap / revenue.
P/B	2.33x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	30.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.9x	Market cap / cash from operations, when positive.
EV/Sales	6.54x	Enterprise value / revenue.
EV/EBIT	53.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	31.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	34.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.3%	Free cash flow / market cap.
Earnings yield	1.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.2%	Dividends paid over the period / market cap.
Shareholder yield	3.0%	(Dividends paid + share buybacks) / market cap.

What was REVVITY, INC.'s revenue in fiscal 2025?

REVVITY, INC. reported revenue of $2.86B for fiscal 2025, 3.7% higher than the year before.

Was REVVITY, INC. profitable in fiscal 2025?

Yes. Net income was $241.2M, a net margin of 8.4%.

How much free cash flow did REVVITY, INC. generate in fiscal 2025?

Cash from operations of $582.9M minus capital expenditures of $73.5M left free cash flow of $509.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to REVVITY, INC.